produce "accurate" results for fresh serum from patients; however, further studies of this effect will be needed if we are to understand the problem. In addition, our study has shown that for the CAP survey materials and the SRM 909 serum Reference Materials, lyophilization of the material plays a significant role in the bias observed on measurement with certain enzymatic methods for cholesterol. From our studies we cannot offer an immediate solution to this problem. It would be helpful to users if manufacturers would provide information on the effect of lyophilized materials for their instruments. Such information does not address the issue that the users of instruments should have adequate materials to verify that their own instruments are accurate. Confidence in our standardization procedures will be greatly enhanced when we better understand the effect of lyophilization.
NazIha F. Nuwayhld, George F. Johnson,' and Ronald D. Feld This is a multipoint kinetic method for simultaneously determining acetoacetate (AcAc) plus f3-hydroxybutyrate and lactate plus pyruvate in a single cuvette of the Multistat III centrifugal analyzer. In the first step, AcAc and pyruvate are completely reduced, using 3-hydroxybutyrate dehydrogenase (EC 1.1.1.30) and lactate dehydrogenase (EC 1.1.1.27) in the presence of excess NADH at pH 7.5, to /3-hydroxybutyrate and lactate, respectively. After dilution, the endogenous p-hydroxybutyrate and lactate and that resulting from reduction are simultaneously oxidized by their respective dehydrogenases in the presence of excess NAD at pH 9.0. Adjustment of the relative enzyme concentrations allows simultaneous estimation of AcAc plus p-hydroxybutyrate and lactate plus pyruvate by analyzing multipoint absorbance data, collected during the oxidation reaction, with use of a two-component linear-regression model. Total run-to-run CVs were 6.4% and 6.1% at 5 mmol/L /3-hydroxybutyrate and 5 mmoi/L lactate, respectively. The method was designed to be useful for identifying the cause of an increased anion gap in serum.
in a discrete analyzer would require a single cuvette for each analyte. Measurement of lactic acid is done enzymatically, but ketone bodies are assayed by use of the semiquantitative nitroprusside test or the enzymatic measurement of BOH and AcAc (6) (7) (8) .
We recently described a kinetic method for measuring the combined concentrations of AcAc plus BOH in patients with diabetic ketoacidosis (9) . We have also shown that multipoint kinetic analysis can be used for detection and quantification of an interferent that differs kinetically from the analyte (10) . Here, we describe a multipoint kinetic method for the simultaneous determination of multiple analytes: AcAc plus BOH, and LACT plus PYRU. The measurement is performed in a single cuvette of a centrifugal analyzer.
This could improve the cost effectiveness and efficiency of determining several analytes.
Because high anion-gap metabolic acidosis may be caused by a concurrent increase in multiple anions, we used this condition as an example to demonstrate the feasibility and the potential use of the multipoint kinetic approach by measuring AcAc plus BOH and LACT plus PYRU in patients with high anion-gap metabolic acidosis. Our method would help in rapidly identifring the contribution of common metabolic anions to the measured anion gap.3
MaterIals and Methods

Materials
Reagents:
Lyophilized 3-hydroxybutyrate dehydrogenase (HBDH, EC 1.1.1.30) from Rhodopseudomonas spheroides; f3-NADH, disodium salt (grade ifi); /3-NAD, approximately 98% pure (grade Ill); lyophilized, salt-free L-lactate dehydrogenase (EC 1.1.1.27) from rabbit muscle; L-(+)-lactic acid (grade L-X, crystalline), lithium salt; pyruvic acid, sodium salt; acetoacetic acid, lithium salt; DL-/3-hydroxybutyric acid, sodium salt; lyophilized alanine aminotransferase (EC 2.6.1.2) from porcine heart; and L-glutamic acid, sodium salt were all from Sigma Chemical Co., St. Louis, MO 63178.
Specimens: Sera from patients with diabetic ketoacidosis and chronic renal failure, submitted to our laboratory for determination of ketone bodies or electrolytes and having an anion gap exceeding 20 mmoIJL, were divided into aliquots and stored at -80 #{176}C until assay. Also, plasma sampled from patients with lactic acidosis and submitted on ice was stored at -20 #{176}C until use. Sera from blood donors were divided into aliquots and stored at -80 #{176}C until used. We assayed all specimens by the present method within three weeks of storage.
Reagent Preparation
Standards: Prepare stock 500 mmol/L solutions of AcAc (5.40 g/100 mL) and DL-BOH (6.30 g/100 mL); and 200 mmoIJL solutions of LACT (1.92 g/100 mL) and PYRU (2.2 g/100 mL) in de-ionized water. The D-BOH concentration is assumed to be one-half that of DL-BOH (11, 12) . Prepare LACT and BOH standards (0, 2.5, 5, 10, and 15 mmol per liter) by making the appropriate dilutions of stock solutions in de-ionized water. Apportion standards and stock solutions of AcAc and BOH and store them as described (9) . Store LACT stock solution and standards at 4#{176}C, and use them within one month. Prepare PYRU stock solution the day of use. For interference studies, we added different concentrations ofbilirubin (0, 12, 25, 50, and 100 mgIL), hemoglobin (310, 620, 1250, 2500, 5000, and 10 000 mgIL), and triglycerides (310, 620, 1250, 2500, 5000, and 10 000 mg/L) to each control as described by Glick and Ryder (13) , and assayed.
Prepare Tris HC1 buffer (pH 9.5), phosphate buffer (pH 6.98), and NADH and NAD solutions as previously described except that the NAD solution is to be twice the concentration specified there (9) . Stability and conditions of storage of these solutions were as previously described (9) .
HBDH: Dissolve 100 U oflyophilized HBDH in 4000 iL of de-ionized water. Divide into aliquots and store at -20 #{176}C until use. This is stable for at least two weeks.
LDH: Dissolve 5000 U of lyophilized lactate dehydrogenase in 400 zL ofde-ionized water. Divide into aliquots and store at -20 #{176}C until use.
ALT: Dissolve 1000 U oflyophilized alanine aminotransferase in 1000 L of de-ionized water. Divide into aliquots and store at -20 #{176}C until use. This is stable for at least two weeks. and 104 j.L of de-ionized water just before the assay. Two hundred microliters of this reagent suffices for simultaneously determining AcAc plus BOH and LACT plus PYRU in 18 samples. When AcAc plus BOH and LACT plus PYRU were measured separately, only the corresponding enzyme was used. The volume of the other enzyme solution was replaced by de-ionized water.
Methods
For all measurements we used the Multistat Ill centrifugal analyzer (MCA) and its loader (Instrumentation Laboratory, Lexington, MA 02173).
Measurement of LACT plus PYRU:
Load sample (2 ML), and reagent 2 (20 j.tL) into the sample (inner) well of the MCA rotor. Load reagent 1(238 FL), and water diluent (10 j.L) into the reagent well cuvette of the same rotor. Transfer the rotor to the analyzer and pre-incubate for 6 mm at 30#{176}C, then start centrifugation to mix sample-well components with those in the reagent well. Record the increase in absorbance at 340 run for two min after a delay of 10 s by using water as the reference blank.
Measurement ofAcAc plus BOH: AcAc plus BOH were measured as previously described (9), with the following modifications: 20 L ofreagent 2, 238 L ofreagent 1, high HBDH concentration, and a 6-mm pre-incubation. Components of the reduction reaction, including NADH, were diluted 14-fold after mixing with those of the oxidation reaction.
Simultaneous measurement of AcAc plus BOH and LACT plus PYRU:
We measured AcAc plus BOH and LACT plus PYRU simultaneously by combining reduction reaction components (reagent 2) of the separate measurements of AcAc plus BOH and LACT plus PYRU in the inner well of the MCA rotor and those of oxidation reaction components (reagent 1) of both reactions in the reagent cuvette well. Load 2 L of sample and 20 jL of reagent 2 into the sample well of the MCA rotor, and 238 L of reagent 1 and 10 L of water diluent into the reagent well of the same rotor. After a 10-s delay after the pre-incubation (6 mm at 30 #{176}C), record the increase in absorbance at 340 nm for 5 mm at 10-s intervals, using water as a blank. In the reagent-well cuvette, the concentration of NADH was diluted 14-fold (optical path, 0.5 cm) and corresponded to a background absorbance of around 1.0 A for a water blank.
We used the following MCA settings: absorbance, 340 rim; temperature, 30 #{176}C; delay time, 10 5; interval time, 10 s; number of intervals, 30; start mode, 2 (pre-incubation).
Cakulations:
We used the two-component, linear-regression (least squares) model as described by Czervionke et al. (10) to estimate the concentrations of AcAc plus BOH and LACT plus PYRU in an unknown sample. Briefly, we compared the absorbance difference of the unknown with the absorbance differences of two aqueous standards (10 mmol/L BOH and 10 mmol/L LACT) at the same time interval, for multiple intervals (at least 13). The concentrations of AcAc plus BOH and LACT plus PYRU in the unknown sample were then estimated by fitting the twocomponent first-order linear-regression equation to the data. The standard error of estimate (SD), which is a measure of the difference between the observed (y) and estimated (9) absorbance, reflects the degree of fit of the model to the data. For the two-component model, the SD is defined as the sum of the squared differences (y. -divided by n -2, where n is the number of data points:
Results and DiscussIon
Principle ofthe Assay
The described method is based on the following enzymecatalyzed reversible reactions: 1) HBDH-catalyzed reaction:
AcAc + NADH + H # BOH + NAD 2) LDH-catalyzed reaction:
PYRU + NADH + H # LACT + NAD
Under appropriate conditions and in the presence of the specific enzymes, these reactions can be made top in either direction. The forward (reduction) reactions are favored by excess NADH and low pH (pH 7.0), and the backward (oxidation) reactions are favored by excess NAD and high pH (pH 9.5) (14-16). Our approach is to drive the reduction reactions to near completion and then measure the reduced species kinetically by the oxidation reactions. AcAc and PYRU are converted completely into BOH and LACT (first stage), and then the concentrations of total BOH and total LACT, representing AcAc plus BOH and LACT plus PYRU, respectively, are measured during their oxidation back to AcAc and PYRU (second stage).
Design of the Multipoint Kinetic Assay
To determine concentrations of AcAc plus BOH and LACT plus PYRU simultaneously by the multipoint kinetic method, using the two-component, linear-regression model, BOH oxidation and LACT oxidation must obey first-order kinetics ( 1 7 and glutamate to the oxidation reaction (cuvette well) results in the alanine aminotransferase-catalyzed conversion of PYRU to alanine, thus favoring LACT oxidation (16). We based the reagent conditions for LACT oxidation on the "Stat-Pack Rapid Lactate Test" kit (Behring Diagnostics, La Jolla, CA 92037). We modified these conditions by increasing the concentrations of alanine aininotransferase, lactate dehydrogenase, and glutamate by as much as sevenfold those recommended by the manufacturer.
This allowed oxidation of LACT to proceed linearly in the presence of NADH (a component of the reduction stage), which is mixed in with the oxidationreaction components. Under the modified conditions, the rate (mA/2 mm) (y)of the reaction was linearly related to the concentration (x) of either PYRU or LACT up to 15 mmol/L. The regression equations were: y = 7.59x + 3.03 (r = 0.998) andy = 7.29x + 2.25 (r = 0.998), respectively. The similarity of the slopes supports the conclusion that reduction of PYRU was complete during the first stage of the assay. HBDH had no effect on either the reduction or the oxidation stage of the lactate dehydrogenase-eatalyzed reaction.
When different concentrations of LACT (2.5-15.0 mmol/ L) and PYRU (2.5-15.0 mmol/L) were mixed together to give a final total concentration of 10 mmoiJL and assayed, the average analytical recovery was 102% (range 98-107%). This indicates that the reduction of PYRU and the oxidation of LACT are independent, with no interaction. The PYRU concentration in serum is about 10% that of LACT (8), sowe do not expect the PYRU in patients' sera to contribute much to the total concentration of LACT plus PYRU. We compared LACT plus PYRU measured as do- 
Simultaneous Measurement of AcAc pius BOH and LACT plus PYRU
Analytical data: Analysis of multipoint kinetic data by using different approaches has been described (10, 18) . In our method, we used the two-component linear-regression approach described by Czervionke et al. (10) to estimate the concentrations of AcAc plus BOH and LACT plus PYRU. Table 1 shows a good estimate of AcAc plus BOH and LACT plus PYRU concentrations in the supplemented control sera, made by use of this approach. Table 1 In our assay the initial absorbance reading is near 1.0 A, so the observed SD,,,,, is primarily due to the measured spectrophotometric noise of the MCA used and not to poor fit of the model. Using two-component linear regression, the SD,,1 range we observed for sera from patients in diabetic ketoacidosis (n = 16), lactic acidosis (n = 20), and chronic renal failure (n = 4) was 0.30-1.25 mA. This is similar to that obtained from the analysis of supplemented control sera or aqueous standards, again demonstrating the good fit of the two-component linear-regression model to the patients' data. 
Analytical Variables
Analytical recovery and precision: For recovery and precision studies on sera we used controls 1 and 2. These controls were designed to contain one component of the HBDH-catalyzed reaction (AcAc or BOH) and one component of the lactate dehydrogenase-catalyzed reaction (PYRU or LACT) in such a way that one component would undergo oxidation only, whereas the other component would be first reduced, then oxidized. This was done to reveal any analytical problem at either stage (reduction or oxidation) of the assay or with any of its components. Analytical recoveries of LACT and PYRU in these controls were assessed in terms of LACT plus PYRU, and those of AcAc and BOH were assessed in terms of AcAc plus BOH (Table 2) . Analytical recoveries of LACT and BOH in serum were similar to those obtained with aqueous studies. When we mixed different concentrations of aqueous BOH (2.5-10 mmol/L) with different concentrations of LACT (2.5-10 mmoIJL) in various combinations and assayed by using the multipoint kinetic method, average recoveries were 98% (range 86-108%) for BOH and 97% (range 89-115%) for LACT. The recovery results in Table 2 show that reduction of AcAc and oxidation of BOH are essentially independent, with no interaction. The presence of different concentrations of BOH does not interfere with the reduction step, nor do various concentrations ofAcAc affect the oxidation step. Therefore, the various concentrations of NADH remaining after the reduction step do not affect the oxidation step. A similar conclusion can be drawn from the oxidation and reduction of LACT and PYRU. The results also show that the reduction-oxidation reaction of AcAc plus BOH is essentially independent of that of LACT plus PYRU.
Within-run precision and day-to-day precision also are shown in Table 2 This was the genesis of our idea for an assay of total metabolic anions to help with interpretation of an increased anion gap.
